product_160

Daudi Electroporation Kit (Burkitt’s Lymphoma Cells)

$179.00$485.00

Kit Size VolumePriceAdd to Cart
4 ml (Catalog #6561)$179.00
30 ml (Catalog #6562)$485.00
SKU: DAUDI

Product Description

NOTE: To place order using Credit Card, P-Card, or Purchase Order – please choose kit size above and click “Add to cart” button. You can place order online without creating an account.

Electroporation Kit for Daudi Cells (Burkitt’s Lymphoma Cells, CCL-213)

  • Electroporation Kit include: electroporation buffer + buffer-specific optimized electroporation protocols
  • Pre-optimized electroporation protocols are provided for delivery of plasmids (DNA), siRNA, mRNA, and proteins
  • Proprietary electroporation buffer formulation mimics cellular cytoplasm composition (superior electropore resealing)s
  • Certified RNAse- and DNAse-free electroporation buffer
  •  Effective electroporation delivery and high cell viability provides reproducible electroporation results
  • High cell viability and superior cell recovery rates
  •  Electroporation protocols are provided with with the purchase of the Electroporation Kit
  • Developed and manufactured by Altogen Biosystems

Electroporation Buffer:
4 mL of electroporation buffer is sufficient for 20 reactions using standard 0.2 cm elecrtoporation cuvette
30 mL of electroporation buffer is sufficient for 150 reactions using standard 0.2 cm elecrtoporation cuvette

Electroporation Efficiency:
Electroporation kit provides 70-85% delivery efficiency of siRNA. Electroporation efficiency was determined by qRT-PCR.

Electroporation Protocol and MSDS:
Electroporation protocols are provided with the purchase of the Electroporation Kit
Download MSDS: [PDF]

Daudi Cell Line:
The Daudi cell line was originally established from the peripheral blood of a 16-year-old male patient who suffered from Burkitt’s lymphoma, a type of cancer of the immune system. These cells were isolated in 1967 by E. Klein and G. Klein. They don’t express beta-2-microglobulin, but are positive for EBNA, VCA, and surface immunoglobin (slg+). This cell line has been tested positive for Epstein-Barr virus. It can be useful for studies of how leukemia forms, and potentially for biomedical research related to certain types of cancer.

Data:
Daudi Cells Electroporation Kit

Selected in vivo transfection product citations (ALTOGEN® IN VIVO Transfection Kits used in the following publications):

  • 2008 454(7203):523-7. Innate immunity induced by composition-dependent RIG-I …Saito et al [PDF]
  • Am J Pathology. 2010 177(4):1870-80. Role of ocular complement factor H in a murine model … Lyzogubov et al [PDF]
  • Nature Biotechnology. 2011 29(4):341-5. Delivery of siRNA to the mouse brain by … Alvarez-Erviti et al [PDF]
  • Cancer Research. 2011 71(15):5144-53. Inhibition of miR-193a expression by… Iliopoulos et al [PDF]

Altogen Biosystems:

Altogen Biosystems is a life sciences company that offers cell type-specific and pre-optimized transfection products, electroporation kits, and in vivo delivery reagents. Advanced formulation of reagents and optimized transfection protocols provide efficient intracellular delivery of protein, DNA, mRNA, shRNA and siRNA molecules. Read more about transfection technology at Altogen’s Transfection Resource.

Altogen Labs Research Services:

Altogen Labs provides GLP-compliant contract research studies for pre-clinical research, IND applications, and drug development. Biology CRO services include: Xenograft models (30+), development of stable cell lines, ELISA assay development, cell-based and tissue targeted RNAi studies, safety pharm/tox assays, and other studies (visit AltogenLabs.com).

Volume Options:

  • 4 ml (Catalog #6561)
  • 30 ml (Catalog #6562)

Additional Information

Kit Size (Volume)

4 ml (Catalog #6561), 30 ml (Catalog #6562)